Baseline and kinetics of serum hepatitis B virus RNA predict response to pegylated interferon-based therapy in patients with hepatitis B e antigen-negative chronic hepatitis B
© 2019 John Wiley & Sons Ltd Serum hepatitis B virus (HBV) RNA has emerged as a novel biomarker of treatment response. This study aimed to investigate the role of this marker in predicting long-term outcome of patients with hepatitis B e antigen (HBeAg)-negative chronic hepatitis B (CHB) recei...
Saved in:
Main Authors: | Umaporn Limothai, Natthaya Chuaypen, Kittiyod Poovorawan, Watcharasak Chotiyaputta, Tawesak Tanwandee, Yong Poovorawan, Pisit Tangkijvanich |
---|---|
Other Authors: | Chulalongkorn University |
Format: | Article |
Published: |
2020
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/50985 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Genetic variation in STAT4 is associated with treatment response to pegylated interferon in patients with chronic hepatitis B
by: Umaporn Limothai, et al.
Published: (2022) -
Next generation sequencing identifies baseline viral mutants associated with treatment response to pegylated interferon in HBeAg-positive chronic hepatitis B
by: Natthaya Chuaypen, et al.
Published: (2020) -
Reverse transcriptase droplet digital PCR vs reverse transcriptase quantitative real-time PCR for serum HBV RNA quantification
by: Umaporn Limothai, et al.
Published: (2020) -
Genetic variation in STAT4 is associated with treatment response to pegylated interferon in patients with chronic hepatitis B
by: Limothai U.
Published: (2023) -
Baseline and on-treatment predictors of chronic hepatitis B patients receiving pegylated interferon therapy in Asia
by: Phunchai Charatcharoenwitthaya, et al.
Published: (2018)